Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

GSK-3: tricks of the trade for a multi-tasking kinase.

Doble BW, Woodgett JR.

J Cell Sci. 2003 Apr 1;116(Pt 7):1175-86. Review.

PMID:
12615961
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation.

Yuan H, Mao J, Li L, Wu D.

J Biol Chem. 1999 Oct 22;274(43):30419-23.

PMID:
10521419
[PubMed - indexed for MEDLINE]
Free Article
3.

The interaction of glycogen synthase kinase-3 (GSK-3) with the cell cycle.

Ryves WJ, Harwood AJ.

Prog Cell Cycle Res. 2003;5:489-95. Review.

PMID:
14593744
[PubMed - indexed for MEDLINE]
4.

Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.

Desbois-Mouthon C, Blivet-Van Eggelpoël MJ, Beurel E, Boissan M, Delélo R, Cadoret A, Capeau J.

Hepatology. 2002 Dec;36(6):1528-36.

PMID:
12447879
[PubMed - indexed for MEDLINE]
5.

Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.

Fishman P, Madi L, Bar-Yehuda S, Barer F, Del Valle L, Khalili K.

Oncogene. 2002 Jun 6;21(25):4060-4.

PMID:
12037688
[PubMed - indexed for MEDLINE]
Free Article
6.

Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.

Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A.

EMBO J. 1998 Mar 2;17(5):1371-84.

PMID:
9482734
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.

Coghlan MP, Culbert AA, Cross DA, Corcoran SL, Yates JW, Pearce NJ, Rausch OL, Murphy GJ, Carter PS, Roxbee Cox L, Mills D, Brown MJ, Haigh D, Ward RW, Smith DG, Murray KJ, Reith AD, Holder JC.

Chem Biol. 2000 Oct;7(10):793-803.

PMID:
11033082
[PubMed - indexed for MEDLINE]
Free Article
8.
9.

Glycogen synthase kinase 3: a key regulator of cellular fate.

Forde JE, Dale TC.

Cell Mol Life Sci. 2007 Aug;64(15):1930-44. Review.

PMID:
17530463
[PubMed - indexed for MEDLINE]
10.

Endogenous IGF-I protects human intestinal smooth muscle cells from apoptosis by regulation of GSK-3 beta activity.

Kuemmerle JF.

Am J Physiol Gastrointest Liver Physiol. 2005 Jan;288(1):G101-10. Epub 2004 Aug 5.

PMID:
15297258
[PubMed - indexed for MEDLINE]
Free Article
11.

Glycogen synthase kinase-3 and Axin function in a beta-catenin-independent pathway that regulates neurite outgrowth in neuroblastoma cells.

Orme MH, Giannini AL, Vivanco MD, Kypta RM.

Mol Cell Neurosci. 2003 Nov;24(3):673-86.

PMID:
14664817
[PubMed - indexed for MEDLINE]
12.

Phosphorylation by glycogen synthase kinase-3 beta down-regulates Notch activity, a link for Notch and Wnt pathways.

Espinosa L, Inglés-Esteve J, Aguilera C, Bigas A.

J Biol Chem. 2003 Aug 22;278(34):32227-35. Epub 2003 Jun 6.

PMID:
12794074
[PubMed - indexed for MEDLINE]
Free Article
13.

Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways.

Manoukian AS, Woodgett JR.

Adv Cancer Res. 2002;84:203-29. Review.

PMID:
11883528
[PubMed - indexed for MEDLINE]
14.

Role for glycogen synthase kinase-3 in NK cell cytotoxicity and X-linked lymphoproliferative disease.

Aoukaty A, Tan R.

J Immunol. 2005 Apr 15;174(8):4551-8.

PMID:
15814676
[PubMed - indexed for MEDLINE]
Free Article
15.

The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation.

Bax B, Carter PS, Lewis C, Guy AR, Bridges A, Tanner R, Pettman G, Mannix C, Culbert AA, Brown MJ, Smith DG, Reith AD.

Structure. 2001 Dec;9(12):1143-52.

PMID:
11738041
[PubMed - indexed for MEDLINE]
Free Article
16.

New steps in the Wnt/beta-catenin signal transduction pathway.

Sakanaka C, Sun TQ, Williams LT.

Recent Prog Horm Res. 2000;55:225-36. Review.

PMID:
11036939
[PubMed - indexed for MEDLINE]
17.

[A new target for diabetes therapy: advances in the research of glycogen synthase kinase-3 inhibitors].

Liu SN, Shen ZF.

Yao Xue Xue Bao. 2007 Dec;42(12):1227-31. Review. Chinese.

PMID:
18338632
[PubMed - indexed for MEDLINE]
18.

The effects of clozapine on the GSK-3-mediated signaling pathway.

Kang UG, Seo MS, Roh MS, Kim Y, Yoon SC, Kim YS.

FEBS Lett. 2004 Feb 27;560(1-3):115-9.

PMID:
14988008
[PubMed - indexed for MEDLINE]
Free Article
19.

Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death.

Cross DA, Culbert AA, Chalmers KA, Facci L, Skaper SD, Reith AD.

J Neurochem. 2001 Apr;77(1):94-102.

PMID:
11279265
[PubMed - indexed for MEDLINE]
20.

Wnt signaling controls the phosphorylation status of beta-catenin.

van Noort M, Meeldijk J, van der Zee R, Destree O, Clevers H.

J Biol Chem. 2002 May 17;277(20):17901-5. Epub 2002 Feb 7.

PMID:
11834740
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk